What is Medical Data Used For?
With worldwide digital developments, we can only assume that data collection and the medical and healthcare industries are bound to be affected. From a clinical trial to technological patient care, decentralized medical data collection is revolutionizing medicine as we know it. Managing millions of patients’ data facilitates patient care globally, including diagnosis, treatment, and person-specific care processes.
Clinical trials can improve peoples’ health through diagnosis, treatment, and so on, and they can also be crucial in creating and developing medication and drugs. Historically, clinical trials were built and carried out on a centralized approach, meaning the database is located, stored, and kept in a location. In contrast, today, a decentralized approach is increasingly preferable. Clinical trials and medical data collection can be used for many reasons. It can go from behavioral trials to screening to diagnostic to quality of life and much more, but each with a defined research purpose.
Let’s Take a Closer Look
Decentralized data collection also helps make information more accessible from various destination points, which is essential for medical uses. One of the most efficient ways to gather data is via decentralized database systems. These systems allow you to create high-value data sets in an organized manner across different locations that are beneficial to record patient data, trial results, etc. By incorporating data version control within these systems, it is possible to enhance data management and the potential of decentralized data collection at all stages in the medical industry.
Why are there more possibilities today with decentralized medical data collection rather than centralized? To better understand the functioning of a centralized collection system and why data collection is shifting away from it, we can look at the most famous case of it in the past century; the COVID-19 pandemic. Previously, clinical trials have been centralized as patients and/or volunteers could be looked after in an appropriately supervised environment for research. With a centralized collection, data collection, studies, and research can be carried out in different locations at specialized sites. Monitoring can facilitate the process through data analysis.
As mentioned, the pandemic put a dent in centralized medical data collection, given trials had to be paused, disrupted, or even stopped, which saw a fall in drugs and medicine creation. Such a disruption emphasized the future of decentralized medical data collection, not limiting therapeutic medication development. Furthermore, the pandemic demonstrated the importance of technology more than ever, with a decisive shift in the societal, cultural, and economical ways of life. This technological rise also affected the medical and healthcare systems, opening possibilities for research and creating the idea of ‘telemedicine’.
It’s no secret that technological advancements facilitate the future of decentralized medical data collection. From wearable devices to electronic record-keeping and phone-based medical applications, virtual medicine is opening the door for decentralizing other health sectors, including clinical trials. There are now endless possibilities with decentralization due to trial material delivery, virtual doctor-to-patient meetings, and delivered devices.
Increasingly, more companies and health institutions are opting for decentralized medical data collection, with data being analyzed remotely and virtually little or no interaction with trial patients and the researchers, doctors, and health professionals involved. Because of reduced costs associated with decentralized medical data collection, there are more opportunities for the medical profession to expand in further areas.
There are also several socio-political advantages, given that access can be improved globally. With less need for infrastructure and material, decentralized medical data collection can limit costs for institutions. Involvement can also increase due to easier access than centralized medical data collection, which can sometimes be difficult because of location.
The improved access through decentralization can also give more accurate, well-rounded results in research provided that elderly people, individuals from abroad, and more can participate through the touch of a screen. This increase in access boasts intent of participation. With decentralized medical data collection, the trial sample size does not have to be limited. Still, it can be established through an individual threshold, depending on the research at play. With rising technological advancements like biometric sensors and wearable devices for specific conditions, data collection can be made swiftly and accurately, considering everyday life factors.
This improves the accuracy of a trial vastly as it does not limit results to a specific moment which is the case with centralized medical data collection. This approach can expand and improve safety measures, diagnostics, and so many more health measures. The mentioned possibilities made possible with decentralization show that there are endless advantages to the process. It will likely continue to evolve, making errors scarce, costs lower, and advancements quicker.
